Newsbenzinga
Core Laboratories Sees Q4 GAAP EPS $0.12-$0.20 vs $0.17 Est; Sees Sales $128.500M-$134.500M vs $133.317M Est
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…